< Back to search
Filter
1
Active & Responsive

A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma
Location: Omaha NE
Sponsor: PeptiDream Inc.

Sex: All

Age: 18+

Code: NCT07688187

Phase1, Recruiting
Active & Responsive

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

for
Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL),
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT07478848

Phase1, Recruiting
Active & Responsive

A Study of ARC-02 in B-cell NHL

for
B-cell Non Hodgkin Lymphoma
Location: Spokane WA, Los Angeles CA
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07691606

Phase1, Recruiting
Active & Responsive

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma,
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 4+

Code: NCT07652580

Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Bath ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase2, Recruiting

Interested in new pancreatic cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

for
T Cell Malignancies
Location: New Haven CT, New York NY, Cleveland OH, Atlanta GA,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07465835

Phase1, Recruiting
Active & Responsive

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

for
Chronic Lymphocytic Leukemia, B-cell Malignancies
Location: Florham Park NJ, Miami Beach FL, Pittsburgh PA,
Sponsor: Curis, Inc.

Sex: All

Age: 18+

Code: NCT07271667

Phase2, Recruiting
Active & Responsive

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

for
Lymphoma, Myeloma, Cytokine Release Syndrome,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 21+

Code: NCT07390071

Recruiting
Active & Responsive

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

for
Mantle Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06357676

Phase1, Phase2, Recruiting
Active & Responsive

A Study of DM005 in Patients With Advanced Solid Tumors

for
Carcinoma, Non-Small-Cell Lung,
Location: Fairfax VA, Detroit MI, Dallas TX
Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd.

Sex: All

Age: 18+

Code: NCT06515990

Phase1, Phase2, Recruiting
Active & Responsive

Amping up With PemJAK

for
Non-Hodgkin Lymphoma, Hodgkin Disease Lymphoma,
Location: New York NY
Sponsor: Seda S. Tolu

Sex: All

Age: 18 - 70+

Code: NCT07283822

Phase2, Recruiting
Active & Responsive

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

for
Germ Cell Tumor
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06937866

Phase1, Phase2, Recruiting
Active & Responsive

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

for
CD30-Positive Diffuse Large B-Cell Lymphoma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 12 - 70+

Code: NCT06176690

Phase1, Recruiting
Active & Responsive

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

for
Colorectal Neoplasms, Breast Neoplasms, Head and Neck Neoplasms,
Location: Toms River NJ, Jersey City NJ, Belleville NJ, Newark NJ,
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT07158164

Recruiting
Active & Responsive

Investigation of Lymph Node Biology in Kidney Cancer

for
Renal Cell Carcinoma (RCC)
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07038733

Recruiting
Active & Responsive

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

for
HLA-A*0201 Positive Cells Present, Clear Cell Sarcoma (CCS)
Location: New York NY, Los Angeles CA
Sponsor: Sarcoma Alliance for Research through Collaboration

Sex: All

Age: 18+

Code: NCT06942442

Phase2, Recruiting
Active & Responsive

Sitagliptin With Pembro in RCC and Melanoma

for
Advanced Renal Cell Carcinoma, Advanced Melanoma
Location: Iowa City IA
Sponsor: Fernando Maciel Barbosa

Sex: All

Age: 18 - 70+

Code: NCT07634380

Phase1, Recruiting
Active & Responsive

Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia

for
T-cell Prolymphocytic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07311746

Phase1, Phase2, Recruiting
Active & Responsive

DBC-664 in Adult Patients With Solid Tumors

for
Malignant Germ Cell Tumor, Lung Adenocarcinoma,
Location: Lake Success NY, East Brunswick NJ, Grand Rapids MI,
Sponsor: Duboce Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07705035

Phase1, Recruiting
Active & Responsive

CD45BE-HSPC + CART-45 Cells

for
B-Cell Non-Hodgkin Lymphoma (NHL), Richter's Transformation,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07451054

Phase1, Recruiting